the role of covalent btkis in the management of cll
Published 1 day ago • 62 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
1:45
deciding which patients with mpns are suitable candidates for interferon-based therapy
-
0:52
is there a role for combination therapy in cml?
-
2:07
novel treatments for mantle cell lymphoma
-
1:31
frontline treatment for cll: the changing paradigm
-
0:44
the role of allosct for r/r lbcl in the era of car-t therapy
-
2:37
the changing role of autosct in mantle cell lymphoma: the impact of novel agents
-
9:14
case of the week: perihilar cholangiocarcinoma/klatskin tumor (ct & mri)
-
4:23
chartese, non-hodgkin lymphoma survivor
-
14:31
chronic lymphocytic leukemia -- cancer guide
-
1:37
the role of ctdna in hodgkin lymphoma
-
3:01
the predictive value of stereotyped bcr subsets in cll
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
3:27
venetoclax: an unmet need in r/r mantle cell lymphoma after btk inhibitors
-
7:01
management of mantle cell lymphoma in the era of novel targeted drugs
-
2:59
clinical trials and novel agents under investigation in t-cell lymphoma
-
2:04
imc-001: preliminary results of novel pd-l1 inhibitor for r/r extranodal nk/t cell lymphoma
-
1:51
refract: standard chemoimmunotherapy versus novel agents in r/r follicular lymphoma
-
3:36
outcomes of patients with newly diagnosed crlf2-rearranged b-all
-
1:56
dr. rule on the role of btk inhibitors in mcl
-
3:51
novel developments in relapsed/refractory hl: checkpoint inhibitors, bispecifics and car-t cells
-
4:03
a review of current and future directions of clinical trials for cll
-
2:11
novel approaches in hl